This approach offers the potential for earlier breast cancer detection by analyzing tumor markers, CEA and CA 15-3, in ISF, compared to traditional blood tests and imaging methods such as micro-CT and ultrasound (Figure 3A) [245]. This evidence concerns the gene CEACAM5 and neoplasm.